Surveillance report describes influenza-associated pediatric deaths in 2024-25 season

Photo by Cht Gsml / Unsplash

CDC MMWR Published April 4, 2026 Medically reviewed April 18, 2026 By Dr. Sofia Müller, MD · Lifespan & Whole-Person Care

Key Takeaway

Note surveillance report confirms influenza-associated pediatric deaths; lacks quantitative data.

This surveillance report from the United States describes influenza-associated pediatric deaths occurring during the 2024-25 influenza season. The report does not provide specific sample size, quantitative results, effect sizes, or comparative data. It confirms the continued occurrence of pediatric mortality associated with influenza infection.

No safety or tolerability data are reported in this descriptive surveillance document. The report does not detail adverse events, serious adverse events, or discontinuations related to influenza infection or any specific interventions.

Key limitations include the absence of specific death counts, rates, or comparative analyses. The report's funding sources and potential conflicts of interest are not reported. As a descriptive surveillance report, it provides no causal evidence or measures of association strength.

For clinical practice, this report serves as a reminder that influenza infection remains associated with pediatric mortality. It underscores the importance of ongoing surveillance but offers no new quantitative data to guide specific prevention or treatment decisions beyond established public health recommendations.